MCO-010

MCO-010 · Nanoscope Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MCO-010, covering 2024-03-22 to 2024-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] [Phase 2]